anewmeds.com (KLTO): Aggregate Business Value
Klotho Neurosciences Inc (KLTO) aims to secure a leadership position in the therapy of Alzheimer's disease and multiple sclerosis, utilizing the innovative Klotho protein to combat neurodegeneration and aging. Price action on GURU.Markets based on the Enterprise Value metric stands at 30.89. The business relies on a virtual management model, where preclinical trials are outsourced to external contractors while fully retaining all intellectual property rights.
Klotho Neurosciences (KLTO) - metric breakdowns and financial figures
The scale of Klotho Neurosciences Inc (KLTO) is determined by the value of its intellectual property in the fight against Alzheimer's disease. The calculated enterprise value combines market capitalization with net debt, reflecting the total acquisition cost of the business. The dynamics of this metric allow market noise to be filtered out from the actual value of the assets. For biopharmaceuticals, this serves as an indicator of the investment attractiveness of innovations in brain cell rejuvenation. The stability of this figure confirms the fundamental resilience of the company.